<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl0002">
 <label>Table 2</label>
 <caption>
  <p>Classification of drugs that have been considered in COVID-19 management.</p>
 </caption>
 <alt-text id="alt0002">Table 2</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top">Status in COVID-19 management</th>
    <th valign="top">Drugs/Approaches</th>
    <th valign="top">Clinical considerations</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top">FDA approved
     <xref rid="bib0032" ref-type="bibr">
      <sup>32</sup>
     </xref>
    </td>
    <td valign="top">1. Remdesivir
     <break/>2. Dexamethasone
     <break/>3. Aviptadil
    </td>
    <td valign="top">Severe cases of COVID-19 and COVID-19 induced ARDS</td>
   </tr>
   <tr>
    <td valign="top">Under clinical trials
     <xref rid="bib0033" ref-type="bibr">
      <sup>33</sup>
     </xref>
    </td>
    <td valign="top">1. Chloroquine
     <break/>2. Hydroxychloroquine
     <break/>3. Lopinavir/Ritonavir
     <break/>4. IFN-α
     <xref rid="tb2fn1" ref-type="table-fn">1</xref>
     <break/>5. IFN-α2b
     <xref rid="tb2fn2" ref-type="table-fn">2</xref>
     <break/>6. Favipiravir
     <break/>7. Umifenovir
     <break/>8. Tocilizumab
     <break/>9. IFN-ß1a
     <xref rid="tb2fn3" ref-type="table-fn">3</xref>
     <break/>10. Ribavirin
     <break/>11. Convalescent plasma
     <break/>12. ECMO
     <xref rid="tb2fn4" ref-type="table-fn">4</xref>
     <break/>13. High-dose vitamin C
     <break/>14. Corticosteroids (Methylprednisolone)
    </td>
    <td valign="top">Patients with confirmed COVID-19</td>
   </tr>
   <tr>
    <td valign="top">Investigational and/or hypothesis</td>
    <td valign="top">1. Desferrioxamine
     <xref rid="bib0034" ref-type="bibr">
      <sup>34</sup>
     </xref>
     <sup>,</sup>
     <xref rid="bib0035" ref-type="bibr">
      <sup>35</sup>
     </xref>
     <break/>2. Teicoplanin
     <xref rid="bib0031" ref-type="bibr">
      <sup>31</sup>
     </xref>
     <break/>3. Etoposide
     <xref rid="bib0036" ref-type="bibr">
      <sup>36</sup>
     </xref>
    </td>
    <td valign="top">-</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <fn id="tb2fn1">
   <label>1</label>
   <p id="notep0007">Interferon alpha</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tb2fn2">
   <label>2</label>
   <p id="notep0008">Interferon alpha 2b</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tb2fn3">
   <label>3</label>
   <p id="notep0009">Interferon beta 1a</p>
  </fn>
 </table-wrap-foot>
 <table-wrap-foot>
  <fn id="tb2fn4">
   <label>4</label>
   <p id="notep0010">Extracorporeal membrane oxygenation</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
